Literature DB >> 12712383

The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.

I Opitz1, H C van der Veen, C Braumann, B Ablassmaier, K Führer, C A Jacobi.   

Abstract

BACKGROUND: The goal of the study was to investigate the influence of adhesion prophylactic substances (Interceed/lntergel) as well as taurolidine/heparin on intraperitoneal tumor growth and the local recurrence rate after laparoscopic cecum resection in a rat tumor model.
METHODS: Sixty BDIX rats were randomized in three therapy groups and one control group. A laparoscopic-assisted cecum resection was performed via three-trocar method after intraperitoneal tumor cell application (10,000 cells) of a colon carcinoma cell line (DHD/K1/TRb) in all animals. According to the randomization, the cecum suture and a 1 x 1-cm peritoneal defect were either covered with Intergel/Interceed or 1 ml of 0.5% taurolidine 10 IU heparin. The control group underwent instillation of 1 ml 0.9% NaCl solution. After 4 weeks the animals were euthanized and intraperitoneal tumor growth, local recurrence rate, and the number of intraperitoneal adhesions were determined.
RESULTS: The local recurrence rate was not significantly affected by any of the substances. Nevertheless, taurolidine/heparin significantly reduced the total number and weight of intraperitoneal metastases. The formation of adhesions was not significantly influenced by adhesion prophylaxis substances or by taurolidine/heparin.
CONCLUSIONS: Taurolidine/heparin led to a significant reduction of intraperitoneal tumor growth after intraperitoneal application, whereas local tumor recurrence was not significantly influenced. This might be due to the number of injected tumor cells in this cell suspension model. Interceed and Intergel did not reduce intraperitoneal tumor growth. Furthermore, adhesion formation was not reduced by any of the substances.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12712383     DOI: 10.1007/s00464-002-9161-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  49 in total

1.  Reduction of adhesion formation by postoperative administration of ionically cross-linked hyaluronic acid.

Authors:  D B Johns; K E Rodgers; W D Donahue; T C Kiorpes; G S diZerega
Journal:  Fertil Steril       Date:  1997-07       Impact factor: 7.329

2.  Gasless laparoscopy may reduce the risk of port-site metastases following laparascopic tumor surgery.

Authors:  D I Watson; G Mathew; T Ellis; C F Baigrie; A M Rofe; G G Jamieson
Journal:  Arch Surg       Date:  1997-02

3.  Impact of gas(less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases.

Authors:  N D Bouvy; R L Marquet; H Jeekel; H J Bonjer
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

4.  Sodium hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm)--does it affect tumor implantation at abdominal wound sites?

Authors:  R A Underwood; J S Wu; M P Wright; M B Ruiz; S M Pfister; J M Connett; J W Fleshman
Journal:  Dis Colon Rectum       Date:  1999-05       Impact factor: 4.585

5.  Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.

Authors:  K Ropponen; M Tammi; J Parkkinen; M Eskelinen; R Tammi; P Lipponen; U Agren; E Alhava; V M Kosma
Journal:  Cancer Res       Date:  1998-01-15       Impact factor: 12.701

6.  Does laparoscopic vs. conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer?

Authors:  S H Kim; J W Milsom; T L Gramlich; S M Toddy; G I Shore; J Okuda; V W Fazio
Journal:  Dis Colon Rectum       Date:  1998-08       Impact factor: 4.585

7.  Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open-label pilot study.

Authors:  M H Thornton; D B Johns; J D Campeau; F Hoehler; G S DiZerega
Journal:  Hum Reprod       Date:  1998-06       Impact factor: 6.918

8.  Early results of laparoscopic surgery for colorectal cancer. Retrospective analysis of 372 patients treated by Clinical Outcomes of Surgical Therapy (COST) Study Group.

Authors:  J W Fleshman; H Nelson; W R Peters; H C Kim; S Larach; R R Boorse; W Ambroze; P Leggett; R Bleday; S Stryker; B Christenson; S Wexner; A Senagore; D Rattner; J Sutton; A P Fine
Journal:  Dis Colon Rectum       Date:  1996-10       Impact factor: 4.585

9.  Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture.

Authors:  R K Phillips; R Hittinger; L Blesovsky; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1984-01       Impact factor: 6.939

10.  Effects of carbon dioxide pneumoperitoneum, air pneumoperitoneum, and gasless laparoscopy on body weight and tumor growth.

Authors:  N D Bouvy; M C Giuffrida; L N Tseng; E W Steyerberg; R L Marquet; H Jeekel; H J Bonjer
Journal:  Arch Surg       Date:  1998-06
View more
  6 in total

1.  Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.

Authors:  G Nestler; H U Schulz; D Schubert; S Krüger; H Lippert; M Pross
Journal:  Surg Endosc       Date:  2004-12-09       Impact factor: 4.584

2.  Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.

Authors:  Ansgar Michael Chromik; Sebastian Huss; Hayssam Osseili; Adrien Daigeler; Sabine Kersting; Dominique Sülberg; Ulrich Mittelkötter; Thomas Herdegen; Waldemar Uhl; Annette M Müller
Journal:  J Carcinog       Date:  2010-04-16

3.  Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.

Authors:  Birgit Hotz; Ulrike Erben; Marco Arndt; Heinz J Buhr; Hubert G Hotz
Journal:  Int J Colorectal Dis       Date:  2014-09-03       Impact factor: 2.571

4.  Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo.

Authors:  M Buchholz; B Majchrzak-Stiller; S Hahn; D Vangala; R W Pfirrmann; W Uhl; C Braumann; A M Chromik
Journal:  BMC Cancer       Date:  2017-03-24       Impact factor: 4.430

Review 5.  Peritoneal response to abdominal surgery: the role of equine abdominal adhesions and current prophylactic strategies.

Authors:  Juliana de Moura Alonso; Ana Liz Garcia Alves; Marcos Jun Watanabe; Celso Antonio Rodrigues; Carlos Alberto Hussni
Journal:  Vet Med Int       Date:  2014-01-20

6.  Development of a standardized laparoscopic caecum resection model to simulate laparoscopic appendectomy in rats.

Authors:  Philipp Lingohr; Jonas Dohmen; Hanno Matthaei; Timo Schwandt; Gun-Soo Hong; Nils Konieczny; Edwin Bölke; Sven Wehner; Jörg C Kalff
Journal:  Eur J Med Res       Date:  2014-06-17       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.